...
首页> 外文期刊>Liver international : >Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
【24h】

Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.

机译:慢性丙型肝炎患者的糖尿病和胰岛素抵抗患病率:与感染乙型肝炎病毒和丙型肝炎病毒的患者进行比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Our aim was to evaluate the relationship between hepatitis C virus (HCV) infection and development of diabetes mellitus (DM) or insulin resistance (IR) in comparison with hepatitis B virus (HBV) infection and eradication of HCV infection by interferon treatment. METHODS: This study consisted of 952 outpatients, including 544 HCV-infected (HCV+chronic), 286 HBV-infected (HBV+chronic) and 122 patients whose HCV was cleared by interferon treatment (HCV+cleared) (diabetes study). Among 849 without overt DM, IR was assessed in 423 patients, including 232 HCV-infected (HCV+chronic), 135 HBV-infected (HBV+chronic) and 56 HCV-eradicated patients (HCV+cleared) (IR substudy). RESULTS: The prevalence of DM in the HBV+chronic, HCV+chronic and HCV+cleared groups was 6.3, 13.6 and 9.0%, respectively (HBV+chronic vs HCV+chronic, P<0.005), in the diabetes study, and the prevalence of IR in the HCV+chronic group (54.3%) was also higher than that in the HBV+chronic (36.3%) (P<0.005) and HCV+cleared groups (35.7%) (P<0.05) in the IR substudy. However, HCV infection was not shown to be independently associated with DM development [odds ratio (OR) 1.669; P=0.0936] and with IR (OR 1.531; P=0.2154) by multivariate analysis in comparison with HBV infection as control. CONCLUSIONS: HCV-infected patients showed a higher prevalence of DM and IR than those with HBV infection. However, in Japan, other confounding factors appeared to be more important risk factors for the development of disturbance in glucose metabolism.
机译:背景/目的:我们的目的是评估丙型肝炎病毒(HCV)感染与糖尿病(DM)或胰岛素抵抗(IR)的发展之间的关系,与乙型肝炎病毒(HBV)感染和干扰素根除HCV感染相比治疗。方法:本研究由952位门诊患者组成,其中包括544例HCV感染(HCV +慢性),286例HBV感染(HBV +慢性)和122例通过干扰素治疗(HCV +清除)清除HCV的患者(糖尿病研究)。在849例无明显DM的患者中,对423例患者进行了IR评估,包括232例HCV感染(HCV +慢性),135例HBV感染(HBV +慢性)和56例HCV消灭(HCV +清除)(IR子研究)。结果:在糖尿病研究中,HBV +慢性,HCV +慢性和HCV +清除组的DM患病率分别为6.3%,13.6%和9.0%(HBV +慢性vs HCV +慢性,P <0.005)。在IR子研究中,HCV +慢性组的IR患病率(54.3%)也高于HBV +慢性组(36.3%)(P <0.005)和HCV +清除组(35.7%)(P <0.05) 。然而,未显示HCV感染与DM发生独立相关[比值比(OR)1.669; P = 0.0936],并通过多变量分析将IR(OR 1.531; P = 0.2154)与HBV感染作对照。结论:HCV感染患者的DM和IR患病率高于HBV感染者。但是,在日本,其他混杂因素似乎是导致葡萄糖代谢紊乱的更重要的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号